<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35832305</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>Treatment with Herbal Formula Extract in the hSOD1<sup>G93A</sup> Mouse Model Attenuates Muscle and Spinal Cord Dysfunction via Anti-Inflammation.</ArticleTitle><Pagination><StartPage>4754732</StartPage><MedlinePgn>4754732</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4754732</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/4754732</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), a multicomplex neurodegenerative disease, has multiple underlying pathological factors and can induce other neuromuscular diseases, leading to muscle atrophy and respiratory failure. Currently, there is no effective drug for treating patients with ALS. Herbal medicine, used to treat various diseases, has multitarget effects and does not usually induce side effects. Each bioactive component in such herbal combinations can exert a mechanism of action to increase therapeutic efficacy. Herein, we investigated the efficacy of an herbal formula, comprising <i>Achyranthes bidentata</i> Blume, <i>Eucommia ulmoides</i> Oliver, and <i>Paeonia lactiflora</i> Pallas, in suppressing the pathological mechanism of ALS in male hSOD1<sup>G93A</sup> mice. Herbal formula extract (HFE) (1&#x2009;mg/g) were orally administered once daily for six weeks, starting at eight weeks of age, in hSOD1<sup>G93A</sup> transgenic mice. To evaluate the effects of HFE, we performed footprint behavioral tests, western blotting, and immunohistochemistry to detect protein expression and quantitative PCR to detect mRNA levels in the muscles and spinal cord of hSOD1<sup>G93A</sup> mice. HFE-treated hSOD1<sup>G93A</sup> mice showed increased anti-inflammation, antioxidation, and regulation of autophagy in the muscles and spinal cord. Thus, HEF can be therapeutic candidates for inhibiting disease progression in patients with ALS. This study has some limitations. Although this experiment was performed only in male hSOD1<sup>G93A</sup> mice, studies that investigate the efficacy of HEF in various ALS models including female mice, such as mice modeling TAR DNA-binding protein 43 (TDP43) and ORF 72 on chromosome 9 (C9<i>orf</i>72) ALS, are required before it can be established that HEF are therapeutic candidates for patients with ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Eun Jin Yang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Eun Jin</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-2963-3923</Identifier><AffiliationInfo><Affiliation>KM Science Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun Hwa</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Clinical Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Mudan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>KM Science Research Division, Korea Institute of Oriental Medicine (KIOM), 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>2</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35832305</ArticleId><ArticleId IdType="pmc">PMC9273397</ArticleId><ArticleId IdType="doi">10.1155/2022/4754732</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rossi S., Cozzolino M., Carr&#xec; M. T. Old versus new mechanisms in the pathogenesis of ALS. Brain pathology . 2016;26(2):276&#x2013;286. doi: 10.1111/bpa.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12355</ArticleId><ArticleId IdType="pmc">PMC8029354</ArticleId><ArticleId IdType="pubmed">26779612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R., Mariotti R. ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles. Frontiers in cellular neuroscience . 2017;11:p. 80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5359305</ArticleId><ArticleId IdType="pubmed">28377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T. W., Borges K. Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Frontiers in neuroscience . 2017;10:p. 611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D., Mansfield C., Moussy A., Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Frontiers in aging neuroscience . 2017;9:p. 68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C., Petrucelli L. Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron . 2019;101(6):1057&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B. J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. The Lancet Neurology . 2018;17(1):94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M. S. A., Ahmad I., Chattopadhyay D. New Look to Phytomedicine : Advancements in Herbal Products as Novel Drug Leads . London: Academic Press; 2019.</Citation></Reference><Reference><Citation>Pan W., Chen X., Bao J., et al. The use of integrative therapies in patients with amyotrophic lateral sclerosis in Shanghai, China. Evidence-based Complementary and Alternative Medicine . 2013;2013:6. doi: 10.1155/2013/613596.613596</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/613596</ArticleId><ArticleId IdType="pmc">PMC3865630</ArticleId><ArticleId IdType="pubmed">24363770</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M., Lee S. H., Yang E. J. Bojungikgi-tang improves muscle and spinal cord function in an amyotrophic lateral sclerosis model. Molecular Neurobiology . 2019;56(4):2394&#x2013;2407.</Citation><ArticleIdList><ArticleId IdType="pubmed">30030751</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H., Yuan Y., Ding F., Liu J., Gu X. The protective effects of Achyranthes bidentata polypeptides against NMDA-induced cell apoptosis in cultured hippocampal neurons through differential modulation of NR2A-and NR2B-containing NMDA receptors. Brain research bulletin . 2008;77(5):274&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">18765272</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Shen H., Yao J., Hu N., Ding F., Gu X. The protective effects of Achyranthes bidentata polypeptides in an experimental model of mouse sciatic nerve crush injury. Brain Research Bulletin . 2010;81(1):25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19646511</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujikawa T., Hirata T., Wada A., et al. Chronic administration of Eucommia leaf stimulates metabolic function of rats across several organs. British Journal of Nutrition . 2010;104(12):1868&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pubmed">20691136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacology &amp; Therapeutics . 2020;207:p. 107452.</Citation><ArticleIdList><ArticleId IdType="pubmed">31836457</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. L., Cai M., Yang E. J. Anti-inflammatory Effects of a Novel Herbal Extract in the Muscle and Spinal Cord of an Amyotrophic Lateral Sclerosis Animal Model. Front Neurosci . 2020;15:p. 743705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632027</ArticleId><ArticleId IdType="pubmed">34858128</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M., Yang E. J. Combined treatment with Bojungikgi-tang and riluzole regulates muscle metabolism and dysfunction in the hSOD1(G93A) mouse model. Antioxidants (Basel) . 11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8944858</ArticleId><ArticleId IdType="pubmed">35326229</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L., McCoy M., Komuro H., et al. Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radical Biology and Medicine . 2022;178:125&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744315</ArticleId><ArticleId IdType="pubmed">34871763</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans M. C., Couch Y., Sibson N., Turner M. R. Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Molecular and Cellular Neuroscience . 2013;53:34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">23110760</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C. V., Cleveland D. W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron . 2006;52(1):39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M. R., Bowser R., Bruijn L., et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration . 2013;14(sup1):19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Burda J. E., Sofroniew M. V. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron . 2014;81(2):229&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984950</ArticleId><ArticleId IdType="pubmed">24462092</ArticleId></ArticleIdList></Reference><Reference><Citation>Debye B., Schm&#xfc;lling L., Zhou L., Rune G., Beyer C., Johann S. Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1 (G93A) ALS mice. Brain Pathology . 2018;28(1):14&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8028558</ArticleId><ArticleId IdType="pubmed">27880990</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J. H., Gautam M., Kocak N., et al. MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology. Journal of neuroinflammation . 2019;16(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822373</ArticleId><ArticleId IdType="pubmed">31666087</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D., Baloh R. H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. The Journal of clinical investigation . 2017;127(9):3250&#x2013;3258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y., Sugimoto H., Ikeda K., Takamiya K., Shiojima T., Kinoshita M. Muscle morphometry in amyotrophic lateral sclerosis. International journal of neuroscience . 1991;58(3-4):165&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">1365039</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z., Fang Q., Ma W., et al. Skeletal muscle atrophy was alleviated by salidroside through suppressing oxidative stress and inflammation during denervation. Frontiers in pharmacology . 2019;10:p. 997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763704</ArticleId><ArticleId IdType="pubmed">31616291</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z., Xiao Q. Impaired autophagic flux contributes to muscle atrophy in obesity by affecting muscle degradation and regeneration. Biochemical and Biophysical Research Communications . 2020;525(2):462&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">32102751</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Ma C., Yi J., et al. Suppressed autophagy flux in skeletal muscle of an amyotrophic lateral sclerosis mouse model during disease progression. Physiological reports . 2015;3(1):p. e12271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387765</ArticleId><ArticleId IdType="pubmed">25602021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A., Shabani M., Alizadeh S., Meshkani R. Interplay between oxidative stress and autophagy function and its role in inflammatory cytokine expression induced by palmitate in skeletal muscle cells. Cytokine . 2020;125:p. 154835.</Citation><ArticleIdList><ArticleId IdType="pubmed">31479873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko F., Abadir P., Marx R., et al. Impaired mitochondrial degradation by autophagy in the skeletal muscle of the aged female interleukin 10 null mouse. Experimental gerontology . 2016;73:23&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725733</ArticleId><ArticleId IdType="pubmed">26596403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Giordano S., Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochemical Journal . 2012;441(2):523&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3258656</ArticleId><ArticleId IdType="pubmed">22187934</ArticleId></ArticleIdList></Reference><Reference><Citation>Levonen A. L., Hill B. G., Kansanen E., Zhang J., Darley-Usmar V. M. Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radical Biology and Medicine . 2014;71:196&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4042208</ArticleId><ArticleId IdType="pubmed">24681256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Li L., Chen S., et al. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Autophagy . 2011;7(4):412&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya A., Bokov A., Muller F. L., et al. Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS. Neurobiology of aging . 2012;33(8):1829&#x2013;1832.</Citation><ArticleIdList><ArticleId IdType="pubmed">21763036</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu P. M., Alway S. E. Mitochondria&#x2010;associated apoptotic signalling in denervated rat skeletal muscle. The Journal of physiology . 2005;565(1):309&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464486</ArticleId><ArticleId IdType="pubmed">15774533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Simonet T., Bauch&#xe9; S., et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain . 2013;136(8):2359&#x2013;2368.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Kim S., Cui X., et al. Transforming growth factor beta (TGF-&#x3b2;) is a muscle biomarker of disease progression in ALS and correlates with Smad expression. PLoS One . 2015;10(9):p. e0138425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574401</ArticleId><ArticleId IdType="pubmed">26375954</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T. J., Waddell D. S., Barrientos T., et al. The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. Journal of Biological Chemistry . 2007;282(46):33752&#x2013;33759.</Citation><ArticleIdList><ArticleId IdType="pubmed">17873280</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Lepore E., Martini M., et al. Metabolic changes associated with muscle expression of SOD1G93A. Frontiers in physiology . 2018;9:p. 831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Crugnola V., Lamperti C., Lucchini V., et al. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Archives of neurology . 2010;67(7):849&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">20625092</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitanio D., Vasso M., Ratti A., et al. Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1G93A mouse model. Antioxidants &amp; redox signaling . 2012;17(10):1333&#x2013;1350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3437050</ArticleId><ArticleId IdType="pubmed">22563797</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. F., Lee Y. C., Lee K. H., et al. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. Journal of biomedical science . 2016;23(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5073438</ArticleId><ArticleId IdType="pubmed">27769241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>